Hidradenitis Suppurativa in Children

[1] Park S.E., Shih T., Dagenet C., Et al., Pediatric hidradenitis suppurativa publication trends: 2012 to 2022, Pediatr Dermatol, 41, 3, pp. 472-475, (2024)

[2] Garg A., Wertenteil S., Baltz R., Et al., Prevalence estimates for hidradenitis suppurativa among children and adolescents in the United States: a gender- and age-adjusted population analysis, J Invest Dermatol, 138, 10, pp. 2152-2156, (2018)

[3] Cotton C.H., Chen S.X., Hussain S.H., Et al., Hidradenitis suppurativa in pediatric patients, Pediatrics, 151, 5, (2023)

[4] Molina-Leyva A., Cuenca-Barrales C., Adolescent-onset hidradenitis suppurativa: prevalence, risk factors and disease features, Dermatology, 235, 1, pp. 45-50, (2019)

[5] Hallock K.K., Mizerak M.R., Dempsey A., Et al., Differences between children and adults with hidradenitis suppurativa, JAMA Dermatol, 157, 9, pp. 1095-1101, (2021)

[6] Seivright J.R., Collier E., Grogan T., Et al., Physical and psychosocial comorbidities of pediatric hidradenitis suppurativa: a retrospective analysis, Pediatr Dermatol, 38, 5, pp. 1132-1136, (2021)

[7] Garg A., Malviya N., Strunk A., Et al., Comorbidity screening in hidradenitis suppurativa: evidence-based recommendations from the US and Canadian hidradenitis suppurativa foundations, J Am Acad Dermatol, 86, 5, pp. 1092-1101, (2022)

[8] Wright S., Strunk A., Garg A., New-onset depression among children, adolescents, and adults with hidradenitis suppurativa, J Am Acad Dermatol, 83, 5, pp. 1360-1366, (2020)

[9] Wright S., Strunk A., Garg A., Prevalence of depression among children, adolescents, and adults with hidradenitis suppurativa, J Am Acad Dermatol, 86, 1, pp. 55-60, (2022)

[10] McAndrew R., Lopes F.C.P.S., Sebastian K., Et al., Quality of life in hidradenitis suppurativa: a cross-sectional study of a pediatric population, J Am Acad Dermatol, 84, 3, pp. 829-830, (2021)

[1] Park S.E., Shih T., Dagenet C., Et al., Pediatric hidradenitis suppurativa publication trends: 2012 to 2022, Pediatr Dermatol, 41, 3, pp. 472-475, (2024)

[2] Garg A., Wertenteil S., Baltz R., Et al., Prevalence estimates for hidradenitis suppurativa among children and adolescents in the United States: a gender- and age-adjusted population analysis, J Invest Dermatol, 138, 10, pp. 2152-2156, (2018)

[3] Cotton C.H., Chen S.X., Hussain S.H., Et al., Hidradenitis suppurativa in pediatric patients, Pediatrics, 151, 5, (2023)

[4] Molina-Leyva A., Cuenca-Barrales C., Adolescent-onset hidradenitis suppurativa: prevalence, risk factors and disease features, Dermatology, 235, 1, pp. 45-50, (2019)

[5] Hallock K.K., Mizerak M.R., Dempsey A., Et al., Differences between children and adults with hidradenitis suppurativa, JAMA Dermatol, 157, 9, pp. 1095-1101, (2021)

[6] Seivright J.R., Collier E., Grogan T., Et al., Physical and psychosocial comorbidities of pediatric hidradenitis suppurativa: a retrospective analysis, Pediatr Dermatol, 38, 5, pp. 1132-1136, (2021)

[7] Garg A., Malviya N., Strunk A., Et al., Comorbidity screening in hidradenitis suppurativa: evidence-based recommendations from the US and Canadian hidradenitis suppurativa foundations, J Am Acad Dermatol, 86, 5, pp. 1092-1101, (2022)

[8] Wright S., Strunk A., Garg A., New-onset depression among children, adolescents, and adults with hidradenitis suppurativa, J Am Acad Dermatol, 83, 5, pp. 1360-1366, (2020)

[9] Wright S., Strunk A., Garg A., Prevalence of depression among children, adolescents, and adults with hidradenitis suppurativa, J Am Acad Dermatol, 86, 1, pp. 55-60, (2022)

[10] McAndrew R., Lopes F.C.P.S., Sebastian K., Et al., Quality of life in hidradenitis suppurativa: a cross-sectional study of a pediatric population, J Am Acad Dermatol, 84, 3, pp. 829-830, (2021)